SR-THAP is a gamma-aminobutyric acid transporter 3 (GAT3) inhibitor with an IC50 of 4.9 µM, and exhibits 42-fold and 23-fold selectivity over GAT1 and GlyT1, respectively. SR-THAP inhibits GABA uptake in mammalian cells. SR-THAP is applicable to the research of epilepsy, Alzheimers disease and ischemic stroke[1].
Molecular Weight:
517.61
CAS Number:
[3098361-74-8]
Formula:
C31H35NO6
Target:
GABA Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
